Neuron23® Inc., a clinical-stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases, today announced a collaboration with ...

Challenges include low awareness of prophylactic benefits, lack of diagnosis facilities ... Dr. Jitendra Singh announced that India has conducted the first human clinical trial of gene therapy for ...

The $1.2 billion company has some of the biggest podcast bros and athletes touting its praises. Is the greens powder the ...

Magnesium supplements are said to help with a long list of ailments: sleep problems, migraine headaches, depression, high ...

The nutritionist also said that “results from a few clinical trials suggest that ashwagandha extracts may ... The study also revealed that benefits were also more prominent in persons with insomnia.

While exercise is generally beneficial for a person's overall health, physical activities may increase the risk of adverse cardiovascular ... support device performance or clinical, or safety outcomes ...

Empagliflozin and GLP-1RA have both previously demonstrated CV benefits in clinical trials, but only a few trials have ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

Real-world data on GLP-1R agonists’ safety in heart failure and CKD patients was investigated using the TriNetX Research ...

Sagimet Biosciences (SGMT) announced the presentation of Phase 2b data demonstrating the anti-fibrotic activity of its fatty acid synthase ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...